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Available online xxxxThe Virtual Cell Based Assay (VCBA) was applied to simulate the long-term (repeat dose) toxic effects of
chemicals, including substances in cosmetics and personal care products. The presented model is an extension
of the original VCBA for simulation of single exposure and is implemented in a KNIME workﬂow. This work illus-
trates the steps taken to simulate the repeateddose effects of two reference compounds, caffeine and amiodarone.
Using caffeine, in vitro experimental viability data in single exposure from two human liver cell lines, HepG2 and
HepaRG, were measured and used to optimize the VCBA, subsequently repeated exposure simulations were run.
Amiodarone was then tested and simulations were performed under repeated exposure conditions in HepaRG.
The results show that the VCBA can adequately predict repeated exposure experiments in liver cell lines. The re-
ﬁned VCBA model can be used not only to support the design of long term in vitro experiments but also practical
applications in risk assessment. Our model is a step towards the development of in silico predictive approaches to
replace, reﬁne, and reduce the in vivo repeated dose systemic toxicity studies in the assessment of human safety.umers and Re
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In order to reduce and eventually replace the use of animals for
predicting toxicity in humans, models based on concentrations that
cause effects in vitrowill have to be developed, taking into consideration
both toxicokinetics (TK) and toxicodynamics (TD). The characterisation
of the concentration that produces an effect (whether this is a perturba-
tion of a molecular pathway or an apical toxic endpoint) is necessary at
two levels: ﬁrst, for in vitro experiments since “nominal” concentrations
do not correspond to real concentrations to which cells are exposed
(Gülden et al., 2001; Groothuis et al., 2015); and, second, for extrapolat-
ing a dose for human toxicity assessment, since for the assessment of a
hazard of a chemical compound, we need to know the true concentra-
tion in the target organ. Normally, concentration-response curves in in
vitro experiments represent the total amount of substance added to a
microtiter-plate well and not the dissolved (free) concentration that
corresponds to a bioavailable fraction, which could induce an effect
(Groothuis et al., 2015; Kramer et al., 2015;Hamon et al., 2015). Howev-
er, these curves (often characterized by their potency parameters, e.g.
IC50 values) do not properly reﬂect the actual concentrations, which in-
duce an effect at the site of action of the chemical in the cell (particular
receptor or enzyme). One possible improvement, already suggested andference Materials,
26, I-21027 Ispra,
en access article under
the Virtual Cell B
16/j.tiv.2016.10.0demonstrated by several research groups (Gülden and Seibert, 2003;
Heringa et al., 2004; DeBruyn and Gobas, 2007; Kramer, 2010), would
be to design in vitro experiments taking into account the toxic (but bio-
available) concentration in the medium which corresponds to the free
dissolved concentration. In order to introduce a correction within the
in vitro experimental set up our group previously developed the Virtual
Cell Based Assay (VCBA) model (Zaldívar et al., 2010; Zaldivar
Comenges et al., 2011; Zaldivar Comenges et al., in press), which can
be considered an integratedmodelling approach to improve the charac-
terisation and analysis of in vitro cell-based assay data.
The VCBAwas originally built using theMatlab platform andwas ap-
plied to study the toxicological effects of chemicals on cells, as assessed
by High Throughput Screening (HTS) and High Content Imaging (HCI)
using single dose exposure conditions (Zaldívar et al., 2010; Zaldivar
Comenges et al., 2011; Zaldívar et al., 2012). Themodel consists of ordi-
nary differential equations whose solution allows the calculation of the
dissolved concentration of a chemical over time, both in the plate and in
the cells. The mathematical modelling of HTS and HCI experiments
serves not only to predict experimental results (e.g. cell viability) but
also to simulate the dynamics of several processes that are not easily
measurable butwhich can be of toxicological relevance. These processes
include chemical losses due to evaporation or adsorption onto plastic, as
well as the effects of chemicals on cell growth and survival.
The integrated modelling approach of the VCBA thus consists of:
– A fate and transport model
– A cell partitioning modelthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
ased Assay: Simulation of repeated exposure experiments in liver cell
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– A toxicity and effect model
This mathematical model takes into account the fate of a compound
in the in vitro cell-based model, based on the partitioning between (i)
the plastic wall, (ii) headspace, (iii) serum proteins, (iv) lipids, and po-
tentially the compound dynamics within the cell. This is driven by a se-
ries of dynamic mass balance equations based on the compound
physico-chemical properties and partitioning. The gas phase was in-
cluded to allow, in a future version of the model, the possible losses
and cross contamination between the 96 wells in the TC plates. The
model is coupled with a cell growth model and a toxic effects model
(Zaldivar Comenges et al., 2011). The cell growthmodel is a typical pop-
ulation model, described in terms of continuous ordinary differential
equations, which ignores population structure by treating all individual
cells as identical. Matrix population models (Caswell, 1989) integrate
population dynamics and population structure and they are very useful
when the life cycle is described in terms of size classes or age classes. In
the case of theHepG2 cell linemodel, the appropriate description corre-
sponds to a four stage-based approach, each stage corresponding to one
of the four cell cycle phases: G1, S, G2, and M (Hartwell and Weinert,
1989). On the other hand theHepaRG cell line does not proliferate (it re-
mains in phase G1). Furthermore the VCBA takes into account the Dy-
namic Energy Budget (DEB) approach, by Kooijman and van Haren
(1990) showing changes in lipid contents and size of the organisms.
The introduction of DEB models into matrix population models was al-
ready used by Lopes et al. (2005), Klanjscek et al. (2006); and Billoir et
al. (2007). Following this approach, the chemical is taken up by the cell
and it partitions instantaneously over three compartments: one aque-
ous fraction and two non-aqueous fractions: structural component
(proteins) and the energy reserves (lipids). The direct toxic effects of a
chemical concentration were related to the internal (intracellular) con-
centration of the toxicant with the no-effect concentration (NEC) for
survival, and the kr, the killing rate of the toxicant (Zaldivar Comenges
et al., in press). The combined model enables simulations of the true
concentrations causing biological perturbations in cells, over time,
given the nominal concentrations applied in a microtiter plate well.
In order to simulate the long-term (repeat dose) effects of chemicals,
there is a need to develop a tool which can predict, in an efﬁcient and
reliable way, the intracellular concentration within the cell after multi-
ple exposures. The following steps were applied in order to perform the
repeated exposure simulations. First, for caffeine, in vitro experimental
data from two human liver cell lines, HepG2 and HepaRG, were obtain-
ed. Second, the single exposure experimental cell viability data were
used to optimize the VCBA (kr and NEC values). The third step after
model optimisation was to simulate the time-dependent response andFig. 1. A graphical representation of the general setup of the automated VCBA implemen
Please cite this article as: Paini, A., et al., Practical use of the Virtual Cell B
lines, Toxicology in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.10.0compare the predicted results with in vitro data found in literature or
achieved experimentally in house; this can be considered as a validation
step of the VCBA for caffeine. In the fourth step, usingHepaRG cells, con-
centration response curves were tested experimentally and simulations
for amiodarone under repeated exposure conditions were performed.
Thus, the VCBA was implemented into a KNIME workﬂow as de-
scribed in Fig. 1, and an extension was made to simulate the repeated
exposure, as illustrated in Fig. 2.
We describe the development of an open source VCBAmethodology
for simulating the long-term (repeat dose) toxic effects of chemicals,
including substances found in cosmetics and personal care products,
in in vitro (liver cell) systems. The approach is based on the previously
developed VCBA model (Migita et al., 2010; Zaldivar Comenges et al.,
2011; Zaldívar et al., 2012) which is re-coded and re-implemented in
the open-source KNIME platform. The usefulness of this tool in simulat-
ing the repeated dose toxicity of selected compounds is illustrated with
reference to two case study compounds: caffeine and amiodarone.
2. Materials and methods
2.1. Chemicals and supplies
HepaRG cells were obtained from Biopredic International (Rennes,
France) and stored in liquid nitrogen. William's E medium, L-glutamine,
penicillin/streptomycin and trypsin-EDTA were purchased from
Invitrogen (San Giuliano Milanese, Italy). HyClone Fetalclone III serum
was from Thermo Scientiﬁc (Pittsburgh, USA). Caffeine (58-08-2; purity
set with HPLC was 99% as reported from supplier), bovine insulin, hy-
drocortisone hemisuccinate, and amiodarone hydrochloride (19774-
82-4; purity by TLC N 98% as reported from supplier) were purchased
from Sigma-Aldrich (Milan, Italy). Tissue culture treated 96 well clear
bottom black polystyrene microplates were acquired from Corning
(Pero, Italy). Fluorescence staining was performed with Hoechst
33342 (Invitrogen).
2.2. Cell culture and differentiation
Differentiated HepaRG cells exhibit many characteristics of primary
human hepatocytes, including morphology and expression of key met-
abolic enzymes, nuclear receptors, and drug transporters (e.g. morphol-
ogy) and aremetabolically competent, thus express relevant phase I and
II enzymes. HepaRG cells were cultured in William's E medium supple-
mented with 10% HyClone Fetalclone III serum, 1% L-glutamine, 1% pen-
icillin/streptomycin, 5 μg/mL insulin and 50 μM hydrocortisone
hemisuccinate. The cells at passage 18 were seeded at a density of 4 ×
106 cells in 150 cm2 ﬂasks and the medium was refreshed every two
days. After two weeks, 1.7% DMSO was added to favour the cellsted into KNIME platform; which consists of three zones: input, model, and output.
ased Assay: Simulation of repeated exposure experiments in liver cell
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Fig. 2. Setup of the automated VCBA for repeated exposure. Themodel is set up to startwith a range of concentrations in single exposure to optimize theNEC and kr. Afterwhich, themodel
will simulate the repeated exposure based on the starting number of cells present at time zero, the nominal concentrations applied, the number of repeated doses and experimental time
point selected.
3A. Paini et al. / Toxicology in Vitro xxx (2016) xxx–xxxundergoing complete hepatocyte differentiation. Finally, the differenti-
ated cells were gently harvested with trypsin-EDTA and seeded into
96-well clear bottom black plates at a density of 50,000 cells/well
using the Starlet Hamilton platform (Agrate Brianza, Italy). Before ex-
posing the cells to amiodarone or caffeine, isolated hepatocyteswere in-
cubated for 72 h in medium without DMSO at 37 °C, 5% CO2, and 100%
humidity.
The human hepatoma derived HepG2 cell line consists of adherent
epithelial-like cells growing as monolayers and in small aggregates.
The seeding density (passage 12) was of 15 ∗ 103 cells/well, cells were
incubated at 37 °C in a humidiﬁed 5% CO2 incubator for a period of
24 h prior to testing (Clothier et al., 2013).
2.3. Repeated exposure of HepaRG to selected chemicals
For the validation of the model, caffeine and amiodarone were used
as test compounds. Concentrations of caffeine, ranging from 0.195 to
75 mM (24 h exposure, single exposure) or 0.0355 mM to 9.1 mM for
the repeated exposure were tested at 24 h, 48 h, 72 h, and 96 h, using
5 or 3 wells for each concentration (technical replicates) respectively.
Amiodarone was tested in HepaRG at eleven concentrations (between
0 and 50 μM) with three biological replicates. The exposure intervals
were: 24 h, 72 h, 7 days, 14 days; at these time points measurements
were performed. The experimental protocols were similar to those pre-
viously reported in Mennecozzi et al. (2011) and in Zaldívar et al.
(2010). Chemicals were initially solubilized in 100% DMSO and then di-
luted in culturing medium with 5% HyClone Fetalclone III serum to ob-
tain a ﬁnal concentration of DMSO of 0.1%. The range of chemical
concentrations, obtained by performing 1:2 serial dilutions, was tested
in isolated hepatocytes from 2-week-old conﬂuent cultures. Cells treat-
ed with only 0.1% of DMSO were included as negative controls (4 repli-
cates per plate).
2.4. Cell staining and high content imaging
At selected time-points (24 h, 72 h, 7 days, and 14 days), treated
HepaRG cells were stained with Hoechst 33342 for 30min. Live cell im-
aging was performed using Cellomics ArrayScan vTi (Thermo Scientiﬁc,
Pittsburgh, PA, USA). A 10× objectivewas used to collect 10 imageﬁelds
per well (starting at the centre of a well) with a XF93 ﬁlter (Omega Op-
tical, Brattleboro, VT). Cell count, nuclear area and intensity (Hoechst
33342 dye), were measured using Cytotoxicity Bioapplications v.4
from Cellomics Scan Software (Thermo Scientiﬁc, Pittsburgh, PA, USA).Please cite this article as: Paini, A., et al., Practical use of the Virtual Cell B
lines, Toxicology in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.10.0The HCI data obtained after cellular exposure were plotted against test-
ed concentrations.
2.5. Viability in HepG2 assessed using MTT assay
HepG2 (human liver carcinoma cells) are adherent, epithelial-like
cells growing as monolayers and in small aggregates. In vitro data gen-
erated in the context of the EU FP6 project ACuteTox were used
(Clothier et al., 2013). The caffeine concentration response curves
(0.0343–75 mM) were generated by using the MTT assay. In brief,
HepG2 cells were cultured in 96-well plates. After 24 h treatment with
caffeine, cells were incubated with the 100 μL MTT solution (0.5 μg/
mL) for 2 h, then washed with 100 μL of pre-warmed phosphate buff-
ered saline (PBS). The formazan formed in the cells was solubilized in
DMSO and measured colorimetrically. The amount of formazan pro-
ducedwas then quantiﬁed using a simple colorimetric assay. The results
were read in a multi-well scanning spectrophotometer (ELISA reader).
Cytotoxicitywas expressed as inhibitory concentration (ICX) of a chem-
ical resulting in an X% reduction of the cell number/viability, as com-
pared to the untreated control. Three biological triplicates were
performed.
2.6. The Virtual Cell Based Assay (VCBA)
The VCBA model (Zaldívar et al., 2010; Zaldivar Comenges et al.,
2011; Zaldívar et al., 2012) was extended to include two different cell
lines, HepG2 and HepaRG. Brieﬂy, the VCBA model integrates: 1) the
in vitro fate and transport model. The fate and transport model calcu-
lates the time-variable chemical concentration in the medium as well
as in the headspace. It takes into account a series of processes including
evaporation, partitioning of chemicals from the dissolved phase to
serum proteins and lipids, adsorption onto the plastic, degradation,
and decomposition. 2) The cell growth and division model. The cell
growth and division model is based on a four stage based approach
(Gérard and Goldbeter, 2009), with each stage corresponding to one
of the four cell cycle phases: G1, S, G2 and M (Zaldívar et al., 2010).
The following cell lines were used: HepaRG and HepG2. For HepaRG
no proliferation occurs, only G1 phase is present, and for HepG2 see
Tables 2 & 3, results Section. 3) The cell partitioning model. In the pres-
ent work liver cells were introduced into the model. This model was
based on the assumption that once the chemical is taken up by the
cell, a partitioning occurs between three compartments: one aqueous
fraction and two non-aqueous fractions corresponding to structural
components (proteins) and energy resources (lipids). 4) Theased Assay: Simulation of repeated exposure experiments in liver cell
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on cell dynamics (survival/mortality) are expressed by using the killing
rate, kr, and the no effect concentration, NEC (Lopes et al., 2005; Billoir
et al., 2007). 5) The experimental set up. This takes into account the sur-
face, area, size and shape of the well or well-plate.
To run themodel a series of input parameters are needed. Some can
be found in the literature, by applying QSARs, or if necessary to obtain
them experimentally. Parameters that are not directly measurable,
such as no effect concentration (NEC) and killing rate (kr), can be calcu-
lated from the in vitroHTS experiments and can be computed by optimi-
sation using an algorithm that minimizes the squares of the differences
between the experimental cell viability and the viability predicted (sim-
ulated) by the model. The model calculates the NEC and kr, using the
following function:
error ¼
Xno exp
i¼1
Viabilityexp−Viabilitysim
 2
ð1Þ
where Viabilitysim and Viabilityexp represent the simulated and experi-
mental cell viabilities, respectively.
The VCBA was implemented in an open source KNIME platform
using the R program (both freely available). KNIME is a user-friendly
graphical workbench for the analysis process such as data access,
data transformation, investigation, visualization and reporting
(http://www.knime.org/). With the Optimization Parameters tab in
the VCBA KNIME workﬂow the model was optimised in an automat-
ed way, as described above. The core model performs a simulation of
the viability for each of the chemical concentrations. The error func-
tion (Eq. (1)) calculates the error from the values of NEC and kr. This
error function is minimized using the optimization function of R, a
graphical representation is created to see the performance of the
model optimization (Fig. 6).3. Results
The following steps were applied in order to perform the repeated
exposure simulations. First, for caffeine, in vitro experimental data
from two human liver cell lines, HepG2 and HepaRG, were obtained.
Second, the single exposure experimental cell viability data were used
to optimize the VCBA model (kr and NEC values). The third step after
model optimisation was to simulate the time-dependent response and
compare the predicted results with in vitro data found in literature or
achieved experimentally in house; this can be considered as a validation
step of the VCBA model for caffeine. In the fourth step, amiodarone
under repeated exposure conditions in HepaRG was applied for
simulations.Fig. 3. 24 h Caffeine effect on cell viability of HepG2 cell line (mean of three biological
replicates), (extract from Clothier et al., 2013).
Please cite this article as: Paini, A., et al., Practical use of the Virtual Cell B
lines, Toxicology in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.10.03.1. In vitro viability data from HepG2 cells
The results show that caffeine exposure to HepG2 for 24 h resulted
in a statistically signiﬁcant reduction of cell viability at the two highest
concentrations of 25 mM and 75 mM. The concentration-response
curve (Fig. 3) obtained was used to optimise the VCBA model in single
exposure mode for the HepG2 cell line.
3.2. In vitro viability data from HepaRG cells - single exposure experiment
The results show that HepaRG cells exposed to caffeine for 24 h un-
dergo a statistically signiﬁcant reduction of cell viability at concentra-
tions higher than 3 mM. This concentration-response curve (Fig. 4)
was used to optimize the VCBA model in single exposure mode for the
HepaRG cell line.
3.3. In vitro viability data from HepaRG - repeated exposure experiment
The results (Fig. 5) show that HepaRG cells exposed to caffeine (0–
9 mM) repeatedly show a statistically signiﬁcant decrease in cell viabil-
ity already at 48 h, but a drastic decrease is found starting from 2.2 mM
at 72 h and 96 h.
3.4. Simulation of the fate of caffeine and amiodarone in HepaRG
Table 1 reports the simulated partitioning, as percent concentration
[%] of both compound tested in HepaRG at 24h, achieved from the fate
model. The medium represents the total starting amount (100%) of
0.155 mM.
The results show that caffeine is more water soluble - up to 94% is in
the dissolved state that could enter the cell. On the contrary, amioda-
rone is more lipophilic - 85% of the chemical binds to lipids and almost
4% migrates into the plastic of the well.
3.5. Validation of VCBA model for repeated exposure to caffeine
HepG2 data taken from the literature (Scheers et al., 2001), were
represented as cell viability in % versus the control (set to be the PI50
at 24 h, PI50 is the concentration of compound needed to reduce the
total protein content to 50% after 24 h of treatment). Following optimi-
zation of the single-exposure VCBA model in a single exposure mode,
these datawere used to compare the VCBAmodel simulations under re-
peated exposure conditions. The data show fast cell death at a concen-
tration of 4.67 mM caffeine within two weeks of exposure (Fig. 7a).
3.6. Simulation in single exposure mode using selected in vitro hepatic cell
lines.
The VCBA growth model was set to only G1 phase for HepaRG cells,
since this cell line is knownnot to proliferate; Tables 2 & 3 report the cell
speciﬁc input parameter to run the VCBA. On the one hand it has beenFig. 4. 24 h Caffeine effect on cell viability of HepaRG cell line (mean of three biological
replicates).
ased Assay: Simulation of repeated exposure experiments in liver cell
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Fig. 5. Effects of repeated exposure of caffeine on HepaRG cell viability (mean of three technical replicates).
Table 2
VCBA parameters for HepaRG and HepG2 cell lines.
Parameter type Abbreviation
used in the
model
HepaRG HepG2 Units
Mass fraction of
compartment fx
(aq-aqueous, l-lipids,
p-proteins)
faq 0.72 (72%) 0.70 (70%) %
weightfL 0.012
(1.2%)
0.06 (6%)
fP 0.268
(26.8%)
(JRC In
house data)
0.24 (24%) (JRC In
house data)
Initial cell radius ro − 8.3057 ∗ 10−6 m
Final cell radius r∞ − 6.592 ∗ 10−6 m
von Bertalanffy's
growth rate
αG − 1.2687 ∗ 10−5
(Zaldívar et al.,
s−1
5A. Paini et al. / Toxicology in Vitro xxx (2016) xxx–xxxshown that HepG2 cells are able to metabolise xenobiotic compounds
leading to toxic effects, including genotoxicity, oxidative stress and mi-
tochondrial dysfunction (Hewitt and Hewitt, 2004; Knasmuller et al.,
2004; O'Brien and Haskins, 2007; Schoonen et al., 2009). On the other
hand, it is undeniable that the HepG2 cells have lost some of the liver-
speciﬁc functions due to immortalisation, in particular the phase I
drug-metabolising enzymes such as CYP2E1 (Boess et al., 2003;
Wilkening and Bader, 2003). The VCBA for this cell line takes into ac-
count the growth (cell cycle) model: G1 – S – G2 – M. The data on the
duration (h) in each stage for HepG2 was taken from Migita et al.
(2010), HepG2 = [51.4, 33.2, 10.7, 4.7] (h), whereas the total duration
was let as an optimization parameter for HepG2. Mortalities were ob-
tained from Kudryavtsev et al. (2004), zi = [0.005, 0.005, 0.04, 0.04]
(h−1). F was also another optimization parameter, which expressed as
a function of cell density
F ¼ F0  exp −
X4
i¼1
Ni=ρ
 !
ð2Þ
for the case of HepG2.Overviewof theHepG2 cell speciﬁc parameter are
listed in Table 2 and values to describe the cell growthmodel is reported
in Table 3.
3.7. Optimization parameter and model calibration in KNIME platform
With the optimization parameters step, as part of the KNIME plat-
form, we set up: (i) No Effect Concentration (NEC) for survival and (ii)
the Killing Rate (kr) of the toxicant. The model was ﬁtted to the exper-
imental value in order to minimise the error, and achieve the optimised
NEC and kr values. To validate the model; the results achieved wereTable 1
VCBA estimates in % of the chemical fate in the different compartments of themodel, using
HepaRG cells.
Mediuma Headspace Dissolved Proteins Lipids Plastic
Caffeine
0.155 mM 100% 1.32E−07 93.95 5.94 0.00122 0.0076
Amiodarone
0.155 mM 100% 1.11E−13 0.0018 10.67 85.44 3.87
a Medium represents the total starting amount (100%) of 0.155 mM.
Please cite this article as: Paini, A., et al., Practical use of the Virtual Cell B
lines, Toxicology in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.10.0compared with the toxicity experimental data performed in repeated
exposure. For caffeine, the VCBA was optimised to minimise the error
in model prediction of the no effect concentration and killing rate,
using experimental values for two cell lines, HepG2 (Fig. 6A) and
HepaRG (Fig. 6B), in single exposure mode. This resulted in the follow-
ing optimised values of NEC and kr for the two cell lines exposed to
caffeine:
HepG2, NEC = 0, kr = 1.1107
HepaRG, NEC = 0, kr = 0.222
3.8. Validation of the Virtual Cell Based Assay for repeated exposure to
caffeine
After the optimisation step of the VCBA performed by using in vitro
data from single exposure experiments, the model was run using the2010, Zaldivar
Comenges et al.,
2011)
Density: protein PP, 1350 1350 g/L
Lipid PL, 900 900 g/L
Aqueous Paq, 1000 1000 g/L
Density cell type P 1072 1085
(Zaldívar et al.,
2010, Zaldivar
Comenges et al.,
2011)
g/L
Serum in medium 10 5 %
ased Assay: Simulation of repeated exposure experiments in liver cell
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Table 3
VCBA parameters for cell growth in HepaRG and HepG2 cells.
HepG2 G1 S G2 M
Duration (h) 51.4 33.03 10.7 4.7
Mortality (h−1) 5.00E−03 5.00E−03 4.00E−02 4.00E−02
Volume (m3) 1.73E−15 2.40E−15 2.40E−15 2.40E−15
Mass (g) 2.08E−09 2.40E−09 2.40E−09 2.40E−09
Initial cell population
(%)
0.514
(51.4%)
0.332
(33.2)
0.107
(10.7%)
0.0469
(4.69%)
Cell division rate 3.81E + 00
HepaRG G1 – – –
Duration (h) 849
Mortality (h−1) 1.19E−15
Volume (m3) 1.67E−15
Mass (g) 1.79E−9
Initial cell population
(%)
1 (100%)
Cell division rate 0
Fig. 6. A. VCBA optimisation using in vitro experimental data obtained by exposing HepG2
cells to caffeine. B. VCBA model optimisation using in vitro experimental data obtained in
HepaRG exposed to caffeine (graphs are output from KNIME workﬂow).
6 A. Paini et al. / Toxicology in Vitro xxx (2016) xxx–xxxoptimisedNEC and kr values (NEC=0, kr= 1.1107).We ran themodel
for repeated exposure in HepG2, selecting an interval time of 1 week.
The VCBA model simulations for HepG2 were compared with in vitro
data found in literature (Scheers et al., 2001), whereas for HepaRG
cells, the simulations were compared with HTS data generated in
house. The simulated cell viability-time curves are depicted in Fig. 7A
and B, along with the experimental data.
3.9. Simulation of repeated exposure effects of amiodarone
The viability of HepaRG cells exposed to amiodarone was tested
in HTS. The NEC and kr were optimised by applying the 24 h exper-
imental data (as done with caffeine), the NEC and kr values
achieved were 0.000692 and 0.199, respectively. These values
were used for simulations of the repeated exposure, shown in Fig.
8 (lines), the results are reported for 5 concentrations out of the
eleven tested (to keep the graphical representation easy to read).
For amiodarone the simulation was based on a 14 days exposure,
covering the treated exposure time intervals. The simulations
were plotted (Fig. 8) with the experimental results (ﬁll mark),
showing a closer ﬁt to the experimental data at the highest tested
concentration. This could be an indication that the partitioning co-
efﬁcients used in the present model are more reliable for simula-
tion of high concentrations.
4. Discussion
In the context of replacing the use of animals in toxicity testing, there
is a need to predict human in vivo toxic doses from concentrations that
cause toxicological effects in relevant in vitro systems. The characterisa-
tion of the concentration that produces an effect (whether this is a per-
turbation of a molecular pathway or an apical toxic endpoint) is
necessary at two levels: ﬁrst, for the correction of in vitro concentration
response curves, since “nominal” concentrations do not represent the
real concentration experienced by the cell; and, second, in extrapolating
in vitro effects to humans, since the true concentration experienced by
cells within the target organ is more relevant for human toxicity
assessment.
In order to address the ﬁrst issue (reﬁnement of in vitro experi-
ments) the Virtual Cell Based Assay (VCBA) was developed (Zaldivar
Comenges et al., in press). The VCBA is amathematical model consisting
of ordinary differential equations the solution ofwhich allows the calcu-
lation of the dissolved concentration of a chemical in cell culture over
time aswell as the internal concentration in the cells, which is currently
applicable to a range of cell lines (3T3c Balbc, HepG2, HepaRG, A459,
and cardiomyocytes). As described in detail in Zaldivar Comenges et
al. (in press), the VCBA comprises of ﬁve interconnected models: i) aPlease cite this article as: Paini, A., et al., Practical use of the Virtual Cell B
lines, Toxicology in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.10.0fate and transport model. ii) a cell partitioning model. iii) a cell growth
and divisionmodel. iv) a toxicity and effects model. v) the experimental
set up.
In the present study, we extended the applicability of the VCBA to
simulate single exposure effects (Zaldívar et al., 2010; Zaldivar
Comenges et al., 2011; Zaldívar et al., 2012) to repeated exposure ef-
fects. The following steps were taken to simulate the repeated exposure
scenario: i) for caffeine, in vitro experimental concentration response
measuring viability from two types of human liver cell lines, HepG2
and HepaRG, were obtained. The concentration response curve range
was selected to be in line with the available experimental data
(Clothier et al., 2013). However, one needs to take into account that in
some cell types hyperosmotic stress occurring at high concentrations
could lead to cytoskeleton rearrangement and cell cycle arrest as well
as protein and DNA damage (Arsenijevic et al., 2013), which eventuallyased Assay: Simulation of repeated exposure experiments in liver cell
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Fig. 7. A. VCBA simulations (lines) at corresponding concentrations used in vitro in HepG2
cells exposed to caffeine (mM) in time (h, hours, w, week). B. VCBA time response
simulations (lines) at corresponding concentrations used in vitro in HepaRG cells
exposed to caffeine (mM) in time (min).
7A. Paini et al. / Toxicology in Vitro xxx (2016) xxx–xxxcould lead to apoptosis (Lang et al., 2006). The strength of this effect on
HepaRG cells should be studied further. ii.) Single experimental cell
viability data were used to optimize the VCBA. iii.) After optimisation
of themodel parameters NEC and kr, these valueswere used to simulate
the time-dependent response and compare the predicted resultswith in
vitro data found in literature for HepG2 and obtained in the laboratory
for HepaRG. We could consider this as a validation step of the caffeine
based VCBA. The same approach was used for amiodarone applied
only to HepaRG cell line. NEC and kr were achieved and tested time-
dependent response curves for several amiodarone concentrations
under repeated exposure conditions. The simulated repeated exposure
showed with caffeine has shown (in HepaRG) a slight overestimationFig. 8. VCBA simulations (lines) at corresponding concentrations used in vitro in HepaRG
cells exposed to amiodarone (μM), simulation line 0 and 6.25 μM are overlapping.
Please cite this article as: Paini, A., et al., Practical use of the Virtual Cell B
lines, Toxicology in Vitro (2016), http://dx.doi.org/10.1016/j.tiv.2016.10.0of the cell viability compared to the in vitro results and only above the
concentration of 4.55 mM the model had same trend as the in vitro
results. This could implicate that the caffeine VCBA model is less
well calibrated for lower concentrations. On the other hand, in case
of HepaRG cells that were exposed repeatedly to amiodarone, the
simulations were much more reliable at the different concentrations
tested in vitro.
Themainmotivation for developing the VCBAmodel was to provide
ameans of simulating the real concentrations that reaches and perturbs
the cells in in vitro experiments, in single (acute) or repeat (chronic) ex-
posure. Since the mathematical model takes in vitro processes
(biokinetics) into account (e.g. losses by evaporation and binding to
the plastic wells), the actual concentrations should reﬂectmore realistic
and reliable dosemetrics of chemical toxicity than the nominal concen-
trations applied in in vitro systems. These simulated concentrations can
thus be used in the design of follow-up in vitro experiments and to im-
prove, for instance, the reliability of in vitro to in vivo extrapolation for
risk assessment purposes. Also, intracellular total concentrations (or
even intracellular free – unbound – concentrations) might provide a
better dose metric than the extracellular concentration in the medium
(total or free). Future work should aim to compare the free (unbound)
extracellular concentrations (IC50 free) with intracellular concentrations
(IC50 int), and check which ones are more predictive in extrapolating in
vitro to in vivo effects. Therefore, there is a need to enrich the database
with additional experimental results coming from the usage of different
chemicals, cell lines, treatment protocols etc., as well as reﬁnement of
the VCBA to take into account more complex systems (e.g., bi-compart-
mental systems, micro-chips) (Armitage et al., 2014; Crean et al., 2014;
Truisi et al., 2015; Wilmes et al., 2013).
Other VCBA likemodels have also been developed to predict repeated
dose. For example, Kramer (2010) used Rainbow trout (Oncorhynchus
mykiss) cell lines RTL-W1and RTgill-W1 to develop aﬁve-compartment
model [air, medium, protein, plastic, cell] to be able to simulate cell vi-
ability effects following repeated exposure to three compounds
(benzo(a)pyrene, 1,2-dichlorobenzene, 1,2,4-trichlorobenzene). Two-
compartment VCBAmodels [medium and cell] plus a sub compartment
formetabolic clearance for primary rat hepatocytes, primary human he-
patocytes, and the HepaRG cell line, were developed to simulate single
and repeated exposure to Chlorpromazine (Broeders et al., 2014). A re-
cent three-compartment [cell, medium, protein] VCBA model was de-
veloped for ibuprofen to simulate repeated exposure and cell viability
effects in primary rat hepatocytes, primary human hepatocytes, and
HepaRG cell line (Truisi et al., 2015). Other models that could probably
be adapted to repeated exposure conditions are those developed by
Armitage et al. (2014) and Stadnicka-Michalak et al. (2014).
To simplify and automate its use the VCBA was implemented as an
open source tool in the KNIME platform. Future human safety assess-
ments will rely increasingly on the use of multi-scale models, such as
Physiologically-Based Kinetic/Dynamic (PBK/D) models and Virtual Cell
Based Assay (VCBA) models, implemented through a combination of
computational tools, in order to perform extrapolations such as in vitro
to in vivo extrapolation (IVIVE). These biologically-based models will
be coupled with chemistry-based prediction models that also automate
the generation of key input parameters such as physicochemical proper-
ties. The development of automated software tools is an important step
in harmonising and expediting the chemical safety assessment process.
We believe that the in silico tool described in this paper (VCBA in re-
peat exposure mode) is a step towards the development of predictive
approaches that could eventually replace, reﬁne and reduce the need
for in vivo repeated dose systemic toxicity studies in the assessment of
human safety.
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